Form 4: PROCEPT BioRobotics Executive Exercises Stock Options
Insider Transaction Report
PROCEPT BioRobotics EVP, CLO, and Corporate Secretary Alaleh Nouri exercised 11,000 stock options at $4.52 per share, increasing direct common stock holdings.
Summary
- Alaleh Nouri, Executive Vice President, Chief Legal Officer, and Corporate Secretary of PROCEPT BioRobotics Corp (PRCT), exercised stock options.
- The transaction, dated August 14, 2025, involved the acquisition of 11,000 shares of common stock.
- The exercise price for these shares was $4.52 per share.
- Following this cash exercise, Nouri directly owns 72,473 shares of common stock.
- The exercised options were fully vested and exercisable.
- Nouri retains 54,452 derivative securities (stock options) after this reported transaction.
Sentiment
Score: 7
Explanation: The exercise of stock options by a key executive indicates confidence in the company's future performance and stock value, which is generally a positive signal for investors.
Positives
- A high-ranking executive exercised a significant number of stock options, indicating confidence in the company's future prospects and stock value.
- The exercise of options at a fixed price suggests the executive believes the current or future market price will be higher, making the exercise profitable.
Negatives
- NA
Risks
- NA
Future Outlook
NA
Management Comments
- NA
Industry Context
NA
Comparison to Industry Standards
- NA
Legal Proceedings
- NA
Related Party Transactions
- NA
Stakeholder Impact
- Shareholders may interpret the executive's option exercise as a positive signal of management's belief in the company's future growth and stock appreciation.
Next Steps
- NA
Key Dates
| Date | Description |
|---|---|
| 08/14/2025 | Date of earliest transaction (stock option exercise) and filing date. |
| 09/27/2028 | Expiration date of the exercised stock option. |
Recommendation
buyThe exercise of stock options by a high-ranking executive suggests strong internal confidence in the company's future prospects and stock appreciation, which can be a positive indicator for investors considering a 'buy' position.
Keywords
PROCEPT BioRobotics, PRCT, Alaleh Nouri, Stock Option Exercise, Insider Transaction, Form 4, Executive Stock Purchase, Biotechnology, Medical Devices
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.